Optibiotix Health Share Discussion Threads

[judijudi] 21/3/2017 18:56

Wreckage,
I personally don't think Opti will do an IPO to raise capital after the split off? Why?
I think the raising of capital will be part of the split. Maybe a discounted rights issue or such like to existing shareholders and the balance possibly to instis or even a JV partner
I see no point in Opti doing 2 separate things to get to the one goal
bwtfdik

[michaelamouse] 21/3/2017 18:23

Darling, now that's not nice, just as well as no one listens to what you say, here is some more , from the very start, hope you like








Someuwin22 Oct '14 - 22:13 - 1 of 20945 0 0
New thread. Header in progress.
someuwin22 Oct '14 - 22:22 - 2 of 20945 0 0
Plus, they are already talking to DuPont, Kraft Foods and GSK etc.
Banshee22 Oct '14 - 22:51 - 3 of 20945 0 0
Can we have that youtube link in the header? and is it possible to get rid of the misleading long term chart which predates OPTI. chrs
The Prophet22 Oct '14 - 23:17 - 4 of 20945 0 0
It's that 3 threads now running on Opti?
I might as well start me own as well!
someuwin23 Oct '14 - 06:10 - 5 of 20945 1 0
TP, I started another thread because the current one is set up by a poster who most users probably have on filter. Thus the thread would be invisible to them.

Plus I like to see the intra-day volume in the chart.

p.s I will add links to the videos in the header later.
BernieBoy23 Oct '14 - 07:59 - 6 of 20945 0 0
1million trade at 9.75. No move in price!
TrottersTrading23 Oct '14 - 08:12 - 7 of 20945 0 0
ok, own up, who put in the £100k this morning ;)
someuwin23 Oct '14 - 08:32 - 8 of 20945 0 0
All the more relevant with increasing NHS funding problems...

"OptiBiotix Health is creating a range of products designed to prevent or manage many of the chronic and debilitating illnesses associated with ‘lifestyleR17; and ageing. The company sees products targeted at lifestyle diseases (diabetes, hypercholesterolemia, obesity) and ‘healthy ageing’ as a growing area of consumer need with current products lacking the underlying scientific evidence base and clinical evidence to allow consumers to purchase products confident of their safety and efficacy. This market has enormous potential driven by macro environmental factors, including an ageing population, rising medical costs, a public health policy shift towards disease prevention and consumer trends towards healthier lifestyles, better nutrition and self-help."
someuwin23 Oct '14 - 09:39 - 9 of 20945 0 0
"OptiBiotix has contracted Nizo to assess each strain's manufacturability, gastrointestinal robustness and activity against bile salts, to determine the best strain(s) to enter human studies of its first product, a capsular food supplement, scheduled for 2015. The work carried out by Nizo has a dual purpose of identifying the best strain for this first product, but will also characterise the three strains in more detail. This reduces the cost, timescale, and development risk for future products such as cholesterol lowering yoghurts, fruit juices, vegetable juices and cereal bars.

Stephen O'Hara, CEO of OptiBiotix, commented: "Pre-clinical claims support is an important milestone in determining which of our three cholesterol reducing Lactobacillus strains is best suited for our first product, and is most likely to lead to a successful outcome in human studies. We expect this work to be completed by the end of 2014 so we can commence human studies in early 2015..."


The human trials should only take 6 months max so I would hope for the share price to be multiples higher by next summer.
Banshee23 Oct '14 - 10:05 - 10 of 20945 1 0
The cholesterol trials will be more like six weeks i think, the advantages of being a food suppliment rather than pharma trial..

The first commercial deal will be for the weight loss product, which is not far off I believe and should come this year. Needless to say the market for a scietifically formulated, key opinion leader driven product of this kind - which can be baked into bread and biscuits etc or put in cereal, yoghurts, fruit juice snack bars etc will be potentially vast.

Hopefully both products will garner lot of tabloid publicity nearer launch time too.
someuwin23 Oct '14 - 12:10 - 11 of 20945 0 0
Cheers Banshee.
TrottersTrading23 Oct '14 - 12:49 - 12 of 20945 0 0
The 1m trade from earlier today is now showing as a sell, can anyone confirm? Suprised a trade of this size did not have a more dramatic impact on the SP?
The Prophet23 Oct '14 - 12:53 - 13 of 20945 1 0
TT
Best indicator is probably the sp, it's going up!
1m trade may not be a buy or sale, could be transfer.

Some good posts on this and the other thread.
Banshee23 Oct '14 - 12:59 - 14 of 20945 1 0
It's unlikely the 1mill trade is a market buy or sell from the Mm's as they would not hold that amount. It's likely to be some kind of price neutral cross trade, ie a pre-arranged buy and sell combined - it is the other trades today that have moved the price up imo.

The big trade just might represent the end of an overhang tho.

[lodger] 21/3/2017 18:10

A 4.5p rise a day keeps the MichaelMouse away ;-)

[wreckage] 21/3/2017 18:01

Right Here Goes:-

Assumptions - 1) Opti own approx 75% of Optibiotheropeutics(OPTC)
2) Balancing 25% is owned by two directors and Manchester College

If Opti disposes of 49% of its holding it still retains a controlling interest in OPTC

I would expect that a proportion of that 49% will be issue to existing shareholders in Opti either free or at a heavily discounted price.

The remaining portion of the 49% will be sold to the market at an agreed price thus increasing Opti's Bank balance and Opti's Shareholder funds.

It is also possible that OPTC may then do an IPO to raise capital.

In Summary the disposal of Optibiotixs investment in Optibiotheropeutics increases the bank balance of Optibiotix but also decreases the value of its investments in its subsidiary(Optibiotheropeutics). any capital gain on the transaction will be held on Optibiotixs Balance Sheet and presumably be available for future dividend distribution.

Wreckage

[nicktopten] 21/3/2017 17:48

I for one am totally surprised that the demerger has been announced, and will proceed before the vita foods show, where it will become a bit clearer what sort of initial revenue Opti will be gaining from Chol/heart products.
The only reason I can think of is that the Skin division is able to stand alone and already has some commercial news to announce.
But on the face of it, delighted with the news and that its all coming together so fast.
Optibiotix give the impression of confidence going forward..... hope that us long term holders can in some way be rewarded for our patience in this demerger.

[michaelmouse] 21/3/2017 17:46

Firstly can I advise anybody with half a brain to filter "michaelamouse".

BTW You can now write a further £400,000 cash off the balance sheet this year with this IPO alone. Having bizarrely lent themselves £400,000 through a convertible loan note, they are now going to convert this loan into shares in the spin-off SkinBiotix.

Financial engineering at its very best. Bizarre.

[michaelamouse] 21/3/2017 17:45

Pleased to hear you like them, love you always


Go to previousGet moreGo to recent postsJump to the specified articleSubmit
BernieBoy21 Mar '17 - 13:22 - 20880 of 20942 0 0
My money is on SKBT
Parob21 Mar '17 - 13:24 - 20881 of 20942 1 0
Next few weeks should be very busy on the news front...
someuwin21 Mar '17 - 13:34 - 20882 of 20942 0 0
Jeremy Vine show talking about eczema today. Massive unmet market right there for SkinBiotix on that treatment alone.
mouse2021 Mar '17 - 13:34 - 20883 of 20942 0 0
Capitalisation value will be very interesting. I recall SoH saying a year ago skin could be worth £250m in a years time. Not that I expect it to float at anywhere near that level but excited to see where it is valued at.
TrottersTrading21 Mar '17 - 13:37 - 20884 of 20942 0 0
My Guess is a £10-15m float
rafboy21 Mar '17 - 13:38 - 20885 of 20942 0 0
Today's news has come sooner than some of us thought. I wonder if this indicates that treatments etc are closer to production than we are aware of?
diamond fibre21 Mar '17 - 13:39 - 20886 of 20942 0 0
Don't forget our other divisions, they might split as well at a later date, I am surprised we have not announced a new patent, but I suppose this things take there time! DIAMOND.
TrottersTrading21 Mar '17 - 13:40 - 20887 of 20942 1 0
possibly more if the II is a household name. They will want money for Clinical trials so minimum they would want to raise is £10m IMO
someuwin21 Mar '17 - 13:41 - 20888 of 20942 0 0
The skin guys have been beavering away in the background for a while now.

I'm sure they will have some significant progress to announce alongside the IPO.

(or maybe announce soon after float to give a good start to trading)
Parob21 Mar '17 - 13:45 - 20889 of 20942 1 0
18 patents...


The Company, based in the UK, has acquired and subsequently further developed technology and intellectual property comprising 18 patent applications founded on scientific evidence and proof of principle studies. The studies indicate that certain molecules found in the human microbiota can be used to protect, manage and restore the skin.
riskybusiness121 Mar '17 - 13:46 - 20890 of 20942 0 0
I agree 10-15£m. The key thing is not to overvalue the stock at listing as it will go nowhere.

I'm pretty sure soh said if the correct steps were taken over time the ip could be worth £250m. No way that's done in a year. Can see skin being worth £40-50m within a year based on potential and successful human studies.
mouse2021 Mar '17 - 13:57 - 20891 of 20942 1 0
I would be very surprised if YSF are not involved seeing as they took funds out of Opti the other week.
Judijudi21 Mar '17 - 14:01 - 20892 of 20942 0 0
I hope they give existing private punters a larger slice of the Cake than the likes of YSF
dlm260221 Mar '17 - 14:02 - 20893 of 20942 1 0
I don't expect OPTI shareholders to get given any Skin biotherapeutics shares when it is listed unless there is an open offer which is available to them. All that will happen is that OPTI will hold whatever %age it holds now less a bit of dilution of a company that is listed rather than unlisted. If Skin biotherapeutics shares rise in value then this should impact OPTI's shares.
mouse2021 Mar '17 - 14:03 - 20894 of 20942 0 0
We deserve it. I suppose the unanswered question is did investors need to hold shares in Opti before today's announcement, or can investors still buy in now and benefit from new shares/warrants.
riskybusiness121 Mar '17 - 14:07 - 20895 of 20942 0 0
By not giving us free shares immediately it prevents those who would sell skin freebies straight away. This would clearly damage skins initial ipo. There will probably be a date from which you will have to hold opti shares to own the proportional holding in skin.
scotty121 Mar '17 - 14:11 - 20896 of 20942 0 0
dlm if my memory serves me correct SOH as already stated at an earlier date that existing shareholders will get a % of shares per their holding in OPTI.
Judijudi21 Mar '17 - 14:12 - 20897 of 20942 1 0
dlm,
Of course existing holders will be offered shares. We will have to pay for them though. At what price and how many (1-1 being banded about) is the question?
scotty121 Mar '17 - 14:18 - 20898 of 20942 0 0
jj existing shareholders may well be offered some to pay for in a open offer but should also receive free ones on a % of what they own in OPTI i wouldn't have thought any were near a 1 to 1 basis though.
mouse2021 Mar '17 - 14:22 - 20899 of 20942 0 0
As Opti own circa 75% of shares, surely the max we could get is 75% of our holdings. All speculation at this stage.
Judijudi21 Mar '17 - 14:23 - 20900 of 20942 1 0
I doubt very much there will be any free share allocation. Just can't see it Mee Sen. We need working capital

[shrewdmole] 21/3/2017 17:37

Look at soh track record he will deliver.

I believe he knows what he has here. If you speak to him he is so passionate about the breakthrough in the science.

S

[michaelmouse] 21/3/2017 17:34

owenmo - post 20938 on the other thread is ludicrous. I started this thread on March 16 2016. The share price at the time was about 75p. It's fluctuated up and down ever since. I've written negatively when the price was higher and lower.

Long term I believe that this is a story stock that has all the hallmarks of those that have gone before e.g Nano, Iofina, Moni etc. In two years time let's see where the company is.

Your next post is correct. A deluge of sells going into the bell at 4:30.

[f3rdinand] 21/3/2017 17:32

Very interesting next few weeks for sure!

[f3rdinand] 21/3/2017 17:32

Will be interesting to see if the skin flotation comes with news of a scientific breakthrough...would certainly help interest in the IPO.

[owenmo] 21/3/2017 17:11

A Red Sea finish - Oy Vey!

[loungeact] 21/3/2017 17:10

Mickeymouse, you really are stupid. Let's assume for a second Johnson & Johnson were keen on collaborating with Opti on some skin products, it'd make sense for them to work/invest/collaborate with Skinbiotix as they would predominantly focus on Skincare, Cosmetics etc.

[owenmo] 21/3/2017 16:59

For the benefit of possible new visitors to this board, attracted maybe by to-day's developments, and then to find the good news in evidence counteracted by a (persistent) naysayer, it may do no harm - even if it won't stave off the rant - to hark back to the beginning of the year. A would-be investor in Opti say in January, who found himself/herself dissuaded by the self-same Jonah who at the time lowered his anticipated share price inevitable decline to 50p, will have forfeited a 35% gain in missed opportunity - had they taken the plunge and sold-on to-day. There is no reason the treat his message today with any less disdain; nor is there any reason to think that a similar gain, and then some, isn't in the offing on the back of the basket of good news coming our way. I have suggested before, and by and largely it's what happens, that his ramblings are ignored rather than responded to. As I started out, however, the above thoughts are for newer visitors. Yes DYOR above all else; but ignore cranks lest you, too, might forfeit a 35% gain there for the taking as events have unfolded and very much against the flow our bogey-man's ill-considered vendetta. OwenM

[michaelmouse] 21/3/2017 16:51

A few investors are clearly wising up to the fact that the "so-called" de-merger is just a fund raising under any other name. Fairly muted reaction to the news.

"You can fool all the people some of the time, and some of the people all the time, but you cannot fool all the people all the time."

Here's a common sense question for the die-hards to mull over. Since OptiBiotix and all it's divisions are "so wonderful" and set to bring in multi-millions then what's the point in "de-risking" the company by spinning each division out?

According to the supporters there isn't any risk. If that's the case then all the divisions would be better held inside the parent company making it into a multi-billion pound enterprise?

Of course the answer is quite simple. Since none of the divisions make anything like meaningful revenues and are years away from making profits, they have to spin divisions out so that they can keep tapping the market for funds without it looking like it's all the same company. Which it is of course.

It's a brave attempt at disguising fund raisings, but "You can fool........etc"

Good luck.

[scotty1] 21/3/2017 16:46

No not all diamond,why because as i said it sounds a little childish,aww why should newbies get in on the new shares we took the risk etc etc.

[diamond fibre] 21/3/2017 16:35

All my posts are silly to you Scotty! Why was my last post silly.

[scotty1] 21/3/2017 16:27

Silly post diamond if you don't mind me saying.Makes you sound a bit childish.

[someuwin] 21/3/2017 16:26

If they really are going for an admission date of 5 April 2017. Then we'll be getting more details soon.

[diamond fibre] 21/3/2017 16:23

The company told all and sundry that they were going to form a new company months ago, so why should New share holders get in on the new shares? After all Optiebiotix shares could have gone down, we took the risk so we should reap the rewards.